Streetbeat News

Stock Prices

MULN

Mullen Automotive shares have resumed trading and experienced a 14% increase.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 2:07 pm

AMZN

GOOGL

META

MSFT

NVDA

Nvidia faces new competition as Cerebras files for an IPO and Huawei pushes AI chips. Nvidia's stock has risen significantly, but analysts warn of its dependency on major customers and potential overhype in AI investments. Cerebras aims to compete with Nvidia, while Huawei targets Nvidia's Chinese customers.

Portfolio Pulse from Anusuya Lahiri

October 01, 2024 | 2:06 pm

BNO

USO

Oil prices are rising due to reports that Iran may be preparing to attack Israel, which could lead to increased geopolitical tensions in the Middle East.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 2:06 pm

NKE

Nike's stock has a significant price level at $88.50, which has acted as both support and resistance due to market psychology and trader behavior. This level is crucial for traders as it reflects remorseful sellers and buyers' remorse, impacting trading decisions.

Portfolio Pulse from Mark Putrino

October 01, 2024 | 2:05 pm

LVO

LiveOne shares have been halted due to a significant upward movement, with the stock now up by 19.10%.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 2:03 pm

EEFT

Euronet Worldwide (NASDAQ:EEFT) has received mixed analyst ratings, with 3 bullish and 1 somewhat bullish ratings in the last three months. Analysts have set a 12-month price target range of $121 to $145, with an average of $129, slightly down from $130. The company shows positive revenue growth but faces challenges with profitability, ROE, ROA, and high debt levels.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 2:02 pm

IPG

Interpublic Group of Companies (NYSE: IPG) has received mixed analyst ratings over the past three months, with a recent downward trend in price targets. Analysts have lowered their ratings and price targets, reflecting cautious sentiment. The average 12-month price target is now $32.29, down from $35.00. Despite positive financial metrics like net margin and ROE, IPG's revenue growth lags behind industry peers, and its debt-to-equity ratio indicates higher financial risk.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 2:02 pm

MXL

MaxLinear (NASDAQ:MXL) has received mixed analyst ratings over the past three months, with a decline in the average 12-month price target. Analysts have adjusted their ratings and price targets, reflecting concerns over MaxLinear's financial health, including a significant revenue decline and below-average profitability metrics.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 2:02 pm

BIO

Bio-Rad Laboratories (NYSE:BIO) has been evaluated by 5 analysts over the past three months, with ratings ranging from bullish to indifferent. The average 12-month price target has increased by 4.17% to $378.4. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Despite these positive analyst actions, Bio-Rad faces financial challenges, including a revenue decline of -6.26%, a net margin of -339.16%, and an ROE of -27.36%.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 2:01 pm

SPY

The USA ISM Manufacturing Prices Index for September came in at 48.3, significantly lower than the estimated 53.5 and the previous month's 54.0. This indicates a decrease in manufacturing prices, which could impact market sentiment.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 2:01 pm